Why a $49 weight-loss pill is rattling Novo Nordisk and Eli Lilly

Novo Nordisk and Eli Lilly are facing an uncomfortable new price point this week after a $49 weight-loss pill jolted the GLP-1 market. By launching a low-cost, compounded oral version of semaglutide, ... ...